Modal Age in Months at Hepatitis B Vaccination* | ||||||
---|---|---|---|---|---|---|
Group | Exposure cohort | Dose 1 | Dose 2 | Dose 3 | Predicted Absolute Change in % Underimmunized at 24 Months in the Suspension vs. Baseline Period† | OR for Being Underimmunized at 24 Months in the Suspension vs. Baseline Period (95% CI)§ |
A | Baseline: | ≤2 | 3–4 | 11–12 | -2% | 0.7 (0.4 – 1.3) |
Suspension: | ≤2 | 3–4 | 11–12 | |||
B | Baseline: | ≤2 | ≤2 | 17–18 | -5%‡ | 0.5 (0.2 – 0.9) |
Suspension: | ≤2 | 3–4 | 11–12 | |||
C | Baseline: | Birth | ≤2 | 5–6 | -3%‡ | 0.8 (0.7 – 0.9) |
Suspension: | ≤2 | 3–4 | 5–6 | |||
D | Baseline: | Birth | ≤2 | 9–10 | +6%‡ | 2.7 (1.7 – 4.4) |
Suspension: | 5–6 | 9–10 | 15–16 | |||
E | Baseline: | Birth | ≤2 | 5–6 | +9%‡ | 3.1 (2.3 – 4.2) |
Suspension: | 5–6 | 9–10 | 11–12 |